{
  "id": "cluster_42_doc2",
  "content": "Research protocol amendment filed April 2023 for NCT04566727 study at Ridgeland, including Korvin's case. Notes indicate exceptional response to combination therapy: 47% reduction in biomarker levels after 3 months. Requires weekly MRI monitoring and caregiver availability due to rapid symptom fluctuation.",
  "metadata": {
    "format": "research_note"
  }
}